Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our Level2View

RGEN
Repligen Corp
stock NASDAQ

Market Open
Jan 22, 2026 10:14:45 AM EST
170.65USD+0.403%(+0.68)60,607
169.19Bid   172.12Ask   2.93Spread
Pre-market
Jan 21, 2026 9:13:30 AM EST
163.00USD-4.101%(-6.97)0
After-hours
Jan 21, 2026 4:00:30 PM EST
169.97USD+0.082%(+0.14)0
OverviewOption ChainMax PainOptionsHistoricalExchange VolumeDark Pool LevelsDark Pool PrintsExchangesShort VolumeShort Interest - DailyShort InterestBorrow Fee (CTB)Failure to Deliver (FTD)ShortsTrendsNewsMore
open chart   
open chart   
Market Cap
9.60B
Headquarters
Waltham, Massachusetts, USA
Industry
Medical Instruments & Supplies
Next Earnings
Feb 19, 2026 (28d)
Related
NVAXNBIXBMRNSGMOBMYGEPFETMOCRLCLBSXLV
RGEN Stats
Avg. Vol. 10 Day
695,434
Avg. Vol. 30 Day
607,021
Employees
476
Market Cap
9,601,794,511
Shares Out.
56,290,749
On/Off Exchange
55%/45%
6 Month Beta
1.35
1 Year Beta
1.45
2 Year Beta
1.39
3 Year Beta
1.44
52 Week Low
102.97
52 Week High
182.52
SMA50
162.20
SMA200
137.35
1 Week
+5.50%
1 Month
+3.02%
3 Month
+8.36%
6 Month
+49.47%
1 Year
+2.24%
2 Year
-7.41%
5 Year
-22.23%
Profile
repligen corporation is a life sciences company focused on the development, production and commercialization of products used in the process of manufacturing biological drugs. our bioprocessing products are sold to major life sciences and biopharmaceutical companies worldwide. we are a leading manufacturer of protein a, a critical reagent used to manufacture monoclonal antibody-based therapeutics. we also supply several growth factor products used to increase cell culture productivity in biomanufacturing. in the burgeoning area of disposable biomanufacturing technologies, we have developed and market a series of opusâ„¢ (open platform user specified) single-use chromatography columns used in the biologics purification process. repligen's corporate headquarters are located in waltham, ma, usa; we have an additional manufacturing facility in lund, sweden.

RGEN Stock Summary

Repligen Corp (NASDAQ:RGEN) stock price today is $170.65, and today's volume is 60,607. RGEN is up 0.403% today. The 30 day average volume is 607,021. RGEN market cap is 9.60B with 56,290,749 shares outstanding.



Share
About
Pricing
Policies
Markets
API
Info
tz UTC-5
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2026 ChartExchange LLC